OBJECTIVES: The intraoperative finding of palpable tumor lesions has been described as a contraindication for nerve-sparing (NS) radical prostatectomy (RP). However, its evaluation is subjective. Especially in patients with a strong demand to regain postoperative erectile function, a surgeon might be reluctant to sacrifice neurovascular bundles (NVBs) based on this information. We investigated the use of frozen section (FS) analysis to monitor the safety and efficiency of NS during RP in patients with intraoperatively identified subcapsular tumor lesions. METHODS: In 83 of 608 patients, who underwent NS-RP, intraoperative FS was performed because of a lesion palpable close to the capsule. A wedge of 4cm in diameter including the lesion was cut off and stained differently for capsule and intraprostatic margin. In case of presence of carcinoma adherent to the capsule, the NVB was resected; otherwise, the NVB remained in situ. RESULTS: Patients with palpable tumor lesions had pT3 tumors in 36% and 61% had Gleason 4 pattern, compared to 18% and 42% for the control group. Carcinoma was found in 93% of the FS specimens. In 42% of the FS samples, tumor had contact with the capsule and 14% of secondary resected NVB specimens demonstrated a carcinoma invasion. In 52% NVBs could be preserved despite an ipsilateral nodule without negatively affecting the margin status. However, the false-negative rate of the FSs was 6%. Conversely, FSs set the intraoperative decision to remove the NVB in 42% of FS patients, resulting in an additional 36% of negative margins. CONCLUSIONS: In patients with intraoperatively detected tumor lesions during a NS planned RP, FS objectively supports the decision of secondary NVB resection as well as preservation.
OBJECTIVES: The intraoperative finding of palpable tumor lesions has been described as a contraindication for nerve-sparing (NS) radical prostatectomy (RP). However, its evaluation is subjective. Especially in patients with a strong demand to regain postoperative erectile function, a surgeon might be reluctant to sacrifice neurovascular bundles (NVBs) based on this information. We investigated the use of frozen section (FS) analysis to monitor the safety and efficiency of NS during RP in patients with intraoperatively identified subcapsular tumor lesions. METHODS: In 83 of 608 patients, who underwent NS-RP, intraoperative FS was performed because of a lesion palpable close to the capsule. A wedge of 4cm in diameter including the lesion was cut off and stained differently for capsule and intraprostatic margin. In case of presence of carcinoma adherent to the capsule, the NVB was resected; otherwise, the NVB remained in situ. RESULTS:Patients with palpable tumor lesions had pT3 tumors in 36% and 61% had Gleason 4 pattern, compared to 18% and 42% for the control group. Carcinoma was found in 93% of the FS specimens. In 42% of the FS samples, tumor had contact with the capsule and 14% of secondary resected NVB specimens demonstrated a carcinoma invasion. In 52% NVBs could be preserved despite an ipsilateral nodule without negatively affecting the margin status. However, the false-negative rate of the FSs was 6%. Conversely, FSs set the intraoperative decision to remove the NVB in 42% of FS patients, resulting in an additional 36% of negative margins. CONCLUSIONS: In patients with intraoperatively detected tumor lesions during a NS planned RP, FS objectively supports the decision of secondary NVB resection as well as preservation.
Authors: Miguel Ramírez-Backhaus; Robert Rabenalt; Sunjay Jain; Minh Do; Evangelos Liatsikos; Roman Ganzer; Lars-Christian Horn; Martin Burchardt; Fernando Jiménez-Cruz; Jens-Uwe Stolzenburg Journal: World J Urol Date: 2008-12-10 Impact factor: 4.226
Authors: Shadab Khan; Aditya Mahara; Elias S Hyams; Alan R Schned; Ryan J Halter Journal: IEEE Trans Med Imaging Date: 2016-06-09 Impact factor: 10.048
Authors: Elmar Heinrich; Georg Schön; Frank Schiefelbein; Maurice Stephan Michel; Lutz Trojan Journal: World J Urol Date: 2010-04-01 Impact factor: 4.226
Authors: Liang Gao; Haijun Zhou; Michael J Thrall; Fuhai Li; Yaliang Yang; Zhiyong Wang; Pengfei Luo; Kelvin K Wong; Ganesh S Palapattu; Stephen T C Wong Journal: Biomed Opt Express Date: 2011-03-18 Impact factor: 3.732
Authors: Roberto Bianchi; Gabriele Cozzi; Giuseppe Petralia; Sarah Alessi; Giuseppe Renne; Danilo Bottero; Antonio Brescia; Antonio Cioffi; Giovanni Cordima; Matteo Ferro; Deliu Victor Matei; Federica Mazzoleni; Gennaro Musi; Francesco Alessandro Mistretta; Alessandro Serino; Valeria Maria Lucia Tringali; Ioan Coman; Ottavio De Cobelli Journal: Medicine (Baltimore) Date: 2016-10 Impact factor: 1.889
Authors: Eoin Dinneen; Aiman Haider; Clare Allen; Alex Freeman; Tim Briggs; Senthil Nathan; Chris Brew-Graves; Jack Grierson; Norman R Williams; Raj Persad; Neil Oakley; Jim M Adshead; Hartwig Huland; Alexander Haese; Greg Shaw Journal: BMJ Open Date: 2019-06-11 Impact factor: 2.692
Authors: Eoin Dinneen; Jack Grierson; Ricardo Almeida-Magana; Rosie Clow; Aiman Haider; Clare Allen; Daniel Heffernan-Ho; Alex Freeman; Tim Briggs; Senthil Nathan; Susan Mallett; Chris Brew-Graves; Nicola Muirhead; Norman R Williams; Elena Pizzo; Raj Persad; Jon Aning; Lyndsey Johnson; Jon Oxley; Neil Oakley; Susan Morgan; Fawzia Tahir; Imran Ahmad; Lorenzo Dutto; Jonathan M Salmond; Anand Kelkar; John Kelly; Greg Shaw Journal: Trials Date: 2022-07-22 Impact factor: 2.728